Delivery Order SPE2DB22D1106-SPE2DB25FFCX2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $15,763.14 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count packages) under a firm fixed price contract. The award was made on August 12, 2025, with an ultimate completion date of August 13, 2025, with no set-aside designation applied. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the prime contractor for this pharmaceutical delivery. This contract represents a...
- The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count packages) on July 29, 2025, with completion targeted for July 30, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order valued at $19,111.33 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This contract, executed on July 29, 2025, with an ultimate completion date of July 30, 2025, utilizes firm fixed-price pricing and was competitively awarded without any set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,195.60 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count) on July 31, 2025, with a completion date of August 1, 2025. The award was made on a firm fixed-price basis with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's leading pharmaceutical distributors and serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $7,441.90 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units) under firm fixed pricing. The award, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a non-competitive delivery against an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its...
- The Defense Logistics Agency awarded a delivery order valued at $15,801.10 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract type. The award was made on August 5, 2025, with an ultimate completion date of August 6, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania serves as the place of performance for this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets in a 60-count configuration, valued at $4,475.14. This competitively awarded, firm fixed-price delivery order was issued on August 1, 2025, with an ultimate completion date of August 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among all eligible vendors....
- The Defense Logistics Agency awarded a delivery order valued at $16,372.36 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed price contract. The award was issued on July 18, 2025, with an ultimate completion date of July 21, 2025, and represents a non-set-aside, competitively awarded procurement. Performance will be completed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $29,840.86 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract. The award was made on August 12, 2025, with an ultimate completion date of August 13, 2025, and performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a $12.5K delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This non-set-aside, firm fixed price delivery order is set to complete by August 13, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier within the federal healthcare procurement...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFCX2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,145.04 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units) under a firm fixed price contract. The award was made on August 12, 2025, with an ultimate completion date of August 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this competitive award. This delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with DLA, operating under the company's larger Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. AmerisourceBergen serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, leveraging this comprehensive IDC vehicle to supply a broad range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/12/25 |